KA 0.60 Kineta, Inc.
| Range: | 0.3339-5.39 | Vol Avg: | 504100 | Last Div: | 0 | Changes: | -0.26 |
| Beta: | 0.57 | Cap: | 0.01B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Thu Feb 11 2016 | Empoloyees: | 11 | ||
| CUSIP: | 49461C102 | CIK: | 0001445283 | ISIN: | US49461C1027 | Country: | US |
| CEO: | Mr. Craig W. Philips | Website: | https://kinetabio.com | ||||
Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
Stock Details
Positive 0.31
Kineta Announces the Extension of the TuHURA Biosciences Exclusivity and Right of First Offer Agreement for KVA12123, Kineta's VISTA blocking antibody Currently in Phase 1
TuHURA has extended their exclusivity and right of first offer pursuant to the terms of th...
globenewswire.com·Wed Oct 02 2024
Positive 0.26
Kineta, Inc Transitioning from Nasdaq to OTC Markets
Kineta will be trading under the symbol “KANT” on OTC Pink Kineta will continue to pursue ...
globenewswire.com·Thu Sep 19 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow